CLOUDR GROUP LTD.

CLOUDR GROUP LTD.

H3L · F · Healthcare / Medical Distribution

0.0305EUR-0.01 (-28.24%)

Price History

Full chart

Market Stats

Previous Close0.0425
Open0.0305
Day Range0.0305 – 0.0305
52-Week Range0.0355 – 0.148
Volume0
Market Cap24.54M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield0.00%
Beta0.30
50-Day Avg0.0469
200-Day Avg0.0661

About

ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) installation to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for patients with chronic condition management. The company's integrated in-hospital solution offers an AI-driven extensive hospital SaaS to assist doctors in diagnosis and treatment, and to help enhance the doctor education; chronic condition management solution to hospitals, including hospital SaaS and proprietary artificial intelligence of things devices. It also offers pharmacy SaaS, which enables in-store, real-time online consultation, prescription, and risk pooling of outpatient services; and sells chronic condition related drugs based on its data insights in pharmacies, including information on inventory, sales, and shipments of prescription drugs. In addition, the company provides integrated in-and out-of-hospital solutions that connect hospitals and pharmacies; insurance brokerage and advertisement agent services; and sells pharmaceuticals, consumables, medical devices, and miscellaneous, as well as chronic condition related drugs. Further, it offers internet and e-commerce services; distributes insurance products; and produces and sells pharmaceutical products. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Ming Kuang
  • Employees776
  • HeadquartersRoom 301 Building 12, Hangzhou, China, Germany
  • Websitehttps://www.cloudr.cn

Leadership

  • Mr. Ming KuangFounder, Chairman & CEO · b. 1982
  • Ms. Yue HuExecutive Director · b. 1976
  • Ms. Lili Xu CPAChief Financial Officer · b. 1982
  • Mr. Gang LiHead of Technology Department · b. 1982
  • Dr. Xiaohua LiuChief Scientist
  • Ms. Wai Sum Fung A.C.I.S., A.C.S.Joint Company Secretary · b. 1983

Financials

Income Statement

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.76B2.99B3.69B3.49B1.62B
Growth (%)-+70.09%+23.51%-5.49%-53.47%
Cost of Revenue1.19B2.20B2.78B2.63B848.10M
Gross Profit570.02M792.10M909.38M861.67M775.08M
Gross Margin32.45%26.51%24.64%24.70%47.75%
Operating Expense1.28B1.36B1.23B1.09B1.06B
Operating Income-708.11M-566.08M-317.75M-233.10M-283.89M
Operating Margin-40.31%-18.94%-8.61%-6.68%-17.49%
EBITDA--1.58B-208.37M-372.34M-884.26M
EBITDA Margin--53.00%-5.65%-10.67%-54.48%
Net Income-4.14B-1.69B-323.06M-516.41M-924.15M
Net Income Margin-235.60%-56.52%-8.75%-14.80%-56.93%
R&D236.24M114.79M88.04M75.40M46.96M
R&D as % of Total Revenue13.45%3.84%2.39%2.16%2.89%
Interest Expense9.61M8.02M10.78M15.45M13.70M
Interest Expense % of Total Revenue0.55%0.27%0.29%0.44%0.84%

Balance Sheet

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.51B2.83B2.95B2.84B1.68B
Total Liabilities9.66B953.05M1.18B1.41B1.20B
Total Equity-7.14B1.85B1.83B1.45B548.55M
Cash1.09B249.67M243.38M304.80M267.63M
Net Debt7.93B-15.35M35.44M642.00K

Cash Flow

Currency: CNY2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-666.33M-642.63M-140.43M-148.39M66.84M
Capital Expenditure88.68M167.24M123.03M76.80M151.51M
Free Cash Flow-755.02M-809.87M-263.46M-225.19M-84.67M
FCF to OCF113.31%126.02%187.61%151.76%-126.68%

Key Statistics & Ratios

Market Cap24.54M
Enterprise Value18.04M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.02
Price / Book0.36
EPS-0.09
Book Value0.1028
Revenue (TTM)1.36B
Gross Profit (TTM)737.81M
EBITDA21.80M
Profit Margin-29.77%
Operating Margin-1.78%
Return on Equity-57.66%
Return on Assets-0.66%
Shares Outstanding645.72M
Shares Float550.29M
Beta0.30
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%